Anna Morozova is a highly experienced regulatory affairs professional with an impressive background in the pharmaceutical industry. She holds a MPharm in Pharmacy from First Moscow State Medical University named after I.M. Sechenov. With over 20 years of experience, Anna has held various senior positions in reputable organizations including GSK, PRA International, and Eisai Pharmaceuticals. Currently, Anna serves as the Scientific and Regulatory Director at REGEM Consulting Ltd, where she leverages her extensive experience in strategic planning, regulatory compliance, and drug development to provide customized regulatory solutions to pharmaceutical companies of all sizes. Prior to this, she served as the Executive Director at RAPIEM. Anna's in-depth knowledge of global regulatory guidelines and requirements, coupled with her expertise in emerging markets, make her a valuable asset in the pharmaceutical industry. Overall, Anna is a dedicated and passionate professional committed to facilitating drug development and ensuring regulatory compliance at every stage of the process.